We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
AusPAR: Keytruda
Australian Public Assessment Report
Device/Product Name
Keytruda
Active ingredients
Pembrolizumab
AusPAR Date
Published
Submission Number
PM-2021-04831-1-4
Submission Type
Extension of indications
Decision
Approved